DCGI gives nod to Serum Institute for phase 2 and 3 human clinical trials of Oxford#39;s COVID-19 vaccine candidate

DCGI gives nod to Serum Institute for phase 2 and 3 human clinical trials of Oxford#39;s COVID-19 vaccine candidate
Currently, phase 2 and 3 clinical trials of Oxford#39;s COVID-19 vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.